1. Market Research
  2. > Pharmaceutical
  3. > Drug Discovery and Development Market Trends
  4. > Renal Stones/Calculi Global Clinical Trials Review, H2, 2015

Renal Stones/Calculi Global Clinical Trials Review, H2, 2015

  • September 2015
  • -
  • Global Data
  • -
  • 81 pages

Renal Stones/Calculi Global Clinical Trials Review, H2, 2015

Summary

GlobalData's clinical trial report, “Renal Stones/Calculi Global Clinical Trials Review, H2, 2015" provides an overview of Renal Stones/Calculi clinical trials scenario. This report provides top line data relating to the clinical trials on Renal Stones/Calculi. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). Global Data Clinical Trial Reports are generated using Global Data’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table Of Contents

Renal Stones/Calculi Global Clinical Trials Review, H2, 2015
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Renal Stones/Calculi 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Renal Stones/Calculi to Genito Urinary System And Sex Hormones Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Renal Stones/Calculi to Genito Urinary System And Sex Hormones Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Renal Stones/Calculi 25
Subjects Recruited Over a Period of Time 28
Clinical Trials by Sponsor Type 29
Prominent Sponsors 30
Top Companies Participating in Renal Stones/Calculi Therapeutics Clinical Trials 31
Prominent Drugs 32
Clinical Trial Profiles 33
Clinical Trial Overview of Top Companies 33
Astellas Pharma Inc. 33
Clinical Trial Overview of Astellas Pharma Inc. 33
Allena Pharmaceuticals, Inc. 34
Clinical Trial Overview of Allena Pharmaceuticals, Inc. 34
The Himalaya Drug Company 35
Clinical Trial Overview of The Himalaya Drug Company 35
Takeda Pharmaceutical Company Limited 36
Clinical Trial Overview of Takeda Pharmaceutical Company Limited 36
Sanofi 37
Clinical Trial Overview of Sanofi 37
Omeros Corporation 38
Clinical Trial Overview of Omeros Corporation 38
Manhattan Campus of the VA NY Harbor Healthcare System 39
Clinical Trial Overview of Manhattan Campus of the VA NY Harbor Healthcare System 39
Einstein Healthcare Network 40
Clinical Trial Overview of Einstein Healthcare Network 40
Apis Flora Industrial e Comercial Ltda. 41
Clinical Trial Overview of Apis Flora Industrial e Comercial Ltda. 41
Allergan Plc 42
Clinical Trial Overview of Allergan Plc 42
Clinical Trial Overview of Top Institutes / Government 43
Fredericia Hosptial 43
Clinical Trial Overview of Fredericia Hosptial 43
Hadassah Medical Organization 44
Clinical Trial Overview of Hadassah Medical Organization 44
HaEmek Medical Center 45
Clinical Trial Overview of HaEmek Medical Center 45
Mashhad University of Medical Sciences 46
Clinical Trial Overview of Mashhad University of Medical Sciences 46
University of British Columbia 47
Clinical Trial Overview of University of British Columbia 47
University of Minnesota 48
Clinical Trial Overview of University of Minnesota 48
University of Texas Southwestern Medical Center at Dallas 49
Clinical Trial Overview of University of Texas Southwestern Medical Center at Dallas 49
Alexandria University 50
Clinical Trial Overview of Alexandria University 50
Amai Charitable Trust 51
Clinical Trial Overview of Amai Charitable Trust 51
Arak University of Medical Sciences 52
Clinical Trial Overview of Arak University of Medical Sciences 52
Five Key Clinical Profiles 53
Appendix 78
Abbreviations 78
Definitions 78
Research Methodology 79
Secondary Research 79
About GlobalData 80
Contact Us 80
Disclaimer 80
Source 81

List of Tables
Renal Stones/Calculi Therapeutics, Global, Clinical Trials by Region, 2015* 7
Renal Stones/Calculi Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Renal Stones/Calculi Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Renal Stones/Calculi Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2015* 10
Renal Stones/Calculi Therapeutics Clinical Trials, Europe, Top Five Countries, 2015* 11
Renal Stones/Calculi Therapeutics Clinical Trials, North America, Top Countries, 2015* 12
Renal Stones/Calculi Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2015* 13
Renal Stones/Calculi Therapeutics Clinical Trials, Central and South America, Top Countries, 2015* 14
Proportion of Renal Stones/Calculi to Genito Urinary System And Sex Hormones Clinical Trials, G7 Countries (%), 2015* 15
Renal Stones/Calculi Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16
Renal Stones/Calculi Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17
Proportion of Renal Stones/Calculi to Genito Urinary System And Sex Hormones Clinical Trials, E7 Countries (%), 2015* 18
Renal Stones/Calculi Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19
Renal Stones/Calculi Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20
Renal Stones/Calculi Therapeutics, Global, Clinical Trials by Phase, 2015* 21
Renal Stones/Calculi Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 22
Renal Stones/Calculi Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23
Renal Stones/Calculi Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24
Renal Stones/Calculi Therapeutics, Global, Suspended Clinical Trials, 2015* 25
Renal Stones/Calculi Therapeutics, Global, Withdrawn Clinical Trials, 2015* 26
Renal Stones/Calculi Therapeutics, Global, Terminated Clinical Trials, 2015* 27
Renal Stones/Calculi Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 28
Renal Stones/Calculi Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 29
Renal Stones/Calculi Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 30
Renal Stones/Calculi Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 31
Renal Stones/Calculi Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 32
Renal Stones/Calculi Therapeutics Clinical Trials Market, Global, Clinical Trials by Astellas Pharma Inc., 2015* 33
Renal Stones/Calculi Therapeutics Clinical Trials Market, Global, Clinical Trials by Allena Pharmaceuticals, Inc., 2015* 34
Renal Stones/Calculi Therapeutics Clinical Trials Market, Global, Clinical Trials by The Himalaya Drug Company, 2015* 35
Renal Stones/Calculi Therapeutics Clinical Trials Market, Global, Clinical Trials by Takeda Pharmaceutical Company Limited, 2015* 36
Renal Stones/Calculi Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi, 2015* 37
Renal Stones/Calculi Therapeutics Clinical Trials Market, Global, Clinical Trials by Omeros Corporation, 2015* 38
Renal Stones/Calculi Therapeutics Clinical Trials Market, Global, Clinical Trials by Manhattan Campus of the VA NY Harbor Healthcare System, 2015* 39
Renal Stones/Calculi Therapeutics Clinical Trials Market, Global, Clinical Trials by Einstein Healthcare Network, 2015* 40
Renal Stones/Calculi Therapeutics Clinical Trials Market, Global, Clinical Trials by Apis Flora Industrial e Comercial Ltda. , 2015* 41
Renal Stones/Calculi Therapeutics Clinical Trials Market, Global, Clinical Trials by Allergan Plc, 2015* 42
Renal Stones/Calculi Therapeutics Clinical Trials Market, Global, Clinical Trials by Fredericia Hosptial, 2015* 43
Renal Stones/Calculi Therapeutics Clinical Trials Market, Global, Clinical Trials by Hadassah Medical Organization, 2015* 44
Renal Stones/Calculi Therapeutics Clinical Trials Market, Global, Clinical Trials by HaEmek Medical Center, 2015* 45
Renal Stones/Calculi Therapeutics Clinical Trials Market, Global, Clinical Trials by Mashhad University of Medical Sciences, 2015* 46
Renal Stones/Calculi Therapeutics Clinical Trials Market, Global, Clinical Trials by University of British Columbia, 2015* 47
Renal Stones/Calculi Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Minnesota, 2015* 48
Renal Stones/Calculi Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Texas Southwestern Medical Center at Dallas, 2015* 49
Renal Stones/Calculi Therapeutics Clinical Trials Market, Global, Clinical Trials by Alexandria University, 2015* 50
Renal Stones/Calculi Therapeutics Clinical Trials Market, Global, Clinical Trials by Amai Charitable Trust, 2015* 51
Renal Stones/Calculi Therapeutics Clinical Trials Market, Global, Clinical Trials by Arak University of Medical Sciences, 2015* 52

List of Figures
Renal Stones/Calculi Therapeutics, Global, Clinical Trials by Region (%), 2015* 7
Renal Stones/Calculi Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Renal Stones/Calculi Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Renal Stones/Calculi Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2015* 10
Renal Stones/Calculi Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015* 11
Renal Stones/Calculi Therapeutics Clinical Trials, North America, Top Countries (%), 2015* 12
Renal Stones/Calculi Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2015* 13
Renal Stones/Calculi Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2015* 14
Proportion of Renal Stones/Calculi to Genito Urinary System And Sex Hormones Clinical Trials, G7 Countries (%), 2015* 15
Renal Stones/Calculi Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16
Renal Stones/Calculi Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17
Proportion of Renal Stones/Calculi to Genito Urinary System And Sex Hormones Clinical Trials, E7 Countries (%), 2015* 18
Renal Stones/Calculi Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19
Renal Stones/Calculi Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20
Renal Stones/Calculi Therapeutics, Global, Clinical Trials by Phase (%), 2015* 21
Renal Stones/Calculi Therapeutics, Global, Clinical Trials In Progress by Phase, 2015* 22
Renal Stones/Calculi Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23
Renal Stones/Calculi Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24
Renal Stones/Calculi Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 28
Renal Stones/Calculi Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 29
Renal Stones/Calculi Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 30
Renal Stones/Calculi Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 31
Renal Stones/Calculi Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 32
GlobalData Methodology 79

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

  • $ 5650
  • Industry report
  • August 2016
  • by MarketsandMarkets

The global clinical trial management system (CTMS) market is estimated to grow at a CAGR of 11.5% from 2016 to 2021, to reach USD 920.0 billion by 2021. The adoption of CTMS software is on the rise across ...

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

  • $ 5650
  • Industry report
  • October 2016
  • by MarketsandMarkets

The global CRO services market is estimated to grow at a CAGR of 7.4% from 2016 to 2021, to reach USD 41.86 billion by 2021 from USD 29.29 billion in 2016. Growth in this market is primarily attributed ...

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

  • $ 4157
  • Industry report
  • November 2016
  • by Stratistics MRC

According to Stratistics MRC, the Global Clinical Trial Management System (CTMS) market is expected to grow from $493.58 million in 2015 to reach $1118.58 million by 2022 with a CAGR of 12.4%. Huge research ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.